News Aptahem beslutar om en företrädesemission av aktier om cirka 9,7 MSEK 7 May, 2025
  • About Aptahem
    • Business Strategy
    • Business Model
    • History
    • Team
  • Portfolio
    • RNA-therapeutics
    • Apta-1
    • Apta-2
    • Apta-3
    • Intellectual Property and Patent
  • Our Research
    • Scientific Collaborations
      • Örebro Consortium
      • Seattle Children’s Research Institute (SCRI)
      • University Health Network (UHN)
    • Publications
    • Production
    • Mechanism of Action
  • About Sepsis
  • Investor
    • Market Potential
    • Company Information
    • Share information
    • General Meetings
    • Largest Owners
    • Financial Reports
      • Annual Reports
      • Interim Reports
    • Financial Calendar
    • Events
    • Share issues
    • Analyzes
    • Nomination Committee
  • Media
    • News
    • Newsletter
    • Presentations
    • Sepsis Seminar 2021
  • Contact
  • Svenska
  • About Aptahem
    • Business Strategy
    • Business Model
    • History
    • Team
  • Portfolio
    • RNA-therapeutics
    • Apta-1
    • Apta-2
    • Apta-3
    • Intellectual Property and Patent
  • Our Research
    • Scientific Collaborations
    • Publications
    • Production
    • Mechanism of Action
  • About Sepsis
  • Investor
    • Market Potential
    • Company Information
    • Share information
    • General Meetings
    • Largest Owners
    • Financial Reports
    • Financial Calendar
    • Events
    • Share issues
    • Analyzes
    • Nomination Committee
  • Media
    • News
    • Newsletter
    • Presentations
    • Sepsis Seminar 2021
  • Contact
Subscribe

  • News
  • Newsletter

Aptahem signs agreement with new contract manufacturer

2019-07-04

Aptahem (publ) announced today that the company has signed an agreement with a GMP-certified (Good Manufacturing Practice) contract manufacturer, LGC Group. LGC Group will manufacture the company’s lead candidate, Apta-1, for the concluding toxicological studies and the production is...

Read More

Aptahem AB

Norra Vallgatan 58
211 22 Malmö
Sweden

E-mail: info@aptahem.com

Sociala medier

Facebook
LinkedIn

To all salespersons

We kindly decline all direct contact with salespersons of different types of products and services.

Copyright © 2025 Aptahem AB. All Rights Reserved. | Privacy Policy | Design by Clavis Communications.